siRNA company Eleven Therapeutics seals $22M funding
Eleven Therapeutics has raised a total of $22 million in seed funding. Among the roster…
Eleven Therapeutics has raised a total of $22 million in seed funding. Among the roster…
The first RNA interference (RNAi) therapy was approved in 2018, after 20 years in development.…
ICL, a global specialty minerals company, and ag-biotech company PlantArcBio, Ltd., have announced the development…
People suffering from a severe blood disorder may only have to take a once-monthly drug…
Therorna Inc., a Chinese biotech company specializing in the development of circular RNA (circRNA) technology-based…
Belgian biopharma firm Ziphius Vaccines is set to collaborate with the University of Antwerp to…
New Zealand biotech company Amaroq Therapeutics said it is progressing towards clinical trials following a…
Attempts to increase global Covid-19 vaccine coverage with a temporary patent waiver have been met…
Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
A once forgotten technology, RNA editing has been gaining traction as a treatment for genetic…
AstraZeneca is recruiting RNAi specialist Silence Therapeutics to develop treatments for cardiovascular, renal, metabolic, and…